Cellebrite DI Ltd.
Stock Forecast, Prediction & Price Target
Cellebrite DI Ltd. (CLBT) stock Price Target by analysts
$21.5
Potential upside: 37.29%
Cellebrite DI Ltd. price prediction
What is Cellebrite DI Ltd. stock analysts` prediction?
Cellebrite DI Ltd. stock forecast: Based on 2 Wall Street analysts` predicted price targets for Cellebrite DI Ltd. in the last 3 months, the avarage price target is $21.5, with a high forecast of $NaN. The average price target represents a 37.29% change from the last price of $15.66.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Cellebrite DI Ltd. stock Price Target by analysts
Full breakdown of analysts given Cellebrite DI Ltd. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Tomer Zilberman Bank of America Securities | 0% 0/2 | 11 months ago | $20 27.71% upside | $18.11 | TheFly | Previous targets (1) |
Jeff Van Rhee Craig-Hallum | 0% 0/2 | about 1 year ago | $23 46.87% upside | $16.87 | TheFly | Previous targets (1) |
Eric Martinuzzi Loop Capital Markets | 0% 0/1 | about 1 year ago | $17 8.55% upside | $16.15 | StreetInsider | Previous targets (0) |
Tomer Zilberman Bank of America Securities | 0% 0/2 | about 1 year ago | $17 8.55% upside | $14.96 | TheFly | Previous targets (1) |
Jeff Van Rhee Craig-Hallum | 0% 0/2 | over 1 year ago | $16 2.17% upside | $11.08 | TheFly | Previous targets (1) |
Cellebrite DI Ltd. Financial Estimates
Cellebrite DI Ltd. Revenue Estimates
Cellebrite DI Ltd. EBITDA Estimates
Cellebrite DI Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $246.24M N/A | $270.65M 9.91% | $325.11M 20.12% | Avg: $445.76M Low: $431.92M High: $462.18M avg. 37.11% | Avg: $528.69M Low: $519.58M High: $541.15M avg. 18.60% | Avg: $574.8M Low: $564.89M High: $588.35M avg. 8.72% | Avg: $649.9M Low: $638.70M High: $665.22M avg. 13.06% |
Net Income
% change YoY
| $71.39M N/A | $120.80M 69.20% | $-81.1M -167.13% | Avg: $34.68M Low: $-64.65M High: $49.44M avg. 142.77% | Avg: $73.18M Low: $57.98M High: $59.75M avg. 110.98% | Avg: $71.33M Low: $69.74M High: $73.52M avg. -2.52% | Avg: $140.71M Low: $137.56M High: $145.02M avg. 97.24% |
EBITDA
% change YoY
| $20.91M N/A | $10.23M -51.04% | $-64.79M -732.92% | Avg: $31.35M Low: $30.37M High: $32.50M avg. 148.38% | Avg: $37.18M Low: $36.54M High: $38.05M avg. 18.60% | Avg: $40.42M Low: $39.72M High: $41.37M avg. 8.72% | Avg: $45.70M Low: $44.91M High: $46.78M avg. 13.06% |
EPS
% change YoY
| $0.5 N/A | $0.64 28.00% | -$0.43 -167.18% | Avg: $0.14 Low: -$0.34 High: $0.26 avg. 132.64% | Avg: $0.31 Low: $0.3 High: $0.31 avg. 120.52% | Avg: $0.38 Low: $0.37 High: $0.39 avg. 21.18% | Avg: $0.74 Low: $0.72 High: $0.76 avg. 97.24% |
Operating Expenses
% change YoY
| $189.86M N/A | $218.86M 15.27% | $238.64M 9.03% | Avg: $221.34M Low: $214.46M High: $229.49M avg. -7.24% | Avg: $262.52M Low: $258.00M High: $268.71M avg. 18.60% | Avg: $285.41M Low: $280.49M High: $292.14M avg. 8.72% | Avg: $322.70M Low: $317.14M High: $330.31M avg. 13.06% |
FAQ
What is Cellebrite DI Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 87.11% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -64.65M, average is 34.68M and high is 49.44M.
What is Cellebrite DI Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 19.37% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $431.92M, average is $445.76M and high is $462.18M.
What is Cellebrite DI Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 92.90% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.34, average is $0.14 and high is $0.26.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Cellebrite DI Ltd. stock. The most successful analyst is Tomer Zilberman.